Understanding the Benefits and Risks of Pharmaceuticals
Understanding the Benefits and Risks of Pharmaceuticals
$30.800 CLP
/
🍃 Impresión OnDemand
La impresión bajo demanda es un modelo de producción en el que los libros se imprimen uno a uno, según se soliciten, evitando el exceso de stock y reduciendo el desperdicio de papel. Esta modalidad no solo cuida el medioambiente, sino que también permite ofrecer una mayor variedad de títulos sin la necesidad de grandes tiradas.
Entre sus principales beneficios se encuentran:
✔ Sostenibilidad: Se imprime solo lo necesario, reduciendo el impacto ambiental.
✔ Disponibilidad de títulos: Permite acceder a libros que de otro modo no estarían en stock.
Debido a este proceso, los libros impresos bajo demanda pueden tener tiempos de entrega mayores en comparación con aquellos que ya cuentan con stock disponible.
Tu información de pago se procesa de forma segura. No almacenamos los datos de tu tarjeta de crédito ni tenemos acceso a tu información de pago.
Understanding the Benefits and Risks of Pharmaceuticals
All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the public has a limited understanding of the benefits and risks of drugs, and many individuals believe that drugs approved by the U.S. Food and Drug Administration (FDA) carry no risks. The FDA is responsible for evaluating and balancing the potential risks of drugs with their potential benefits. Assessing, managing, and communicating the benefit-risk profile of a pharmaceutical product is a complex and nuanced scientific, political, and sociological challenge. Once the assessment is made, the FDA is then responsible for managing how to communicate these risks and make healthcare decisions based on them.To explore these issues, the Forum on Drug Discovery, Development, and Translation conducted a public workshop entitled Understanding the Benefits and Risks of Pharmaceuticals, with the broad goals of gaining a better understanding of the current system used to evaluate benefit and risk, and to identify opportunities for improvement. This workshop was held in Washington, D.C., on May 30-31, 2006. The benefit-risk profiles of pharmaceuticals are constantly evolving as new data are collected throughout the life cycle of a drug. Discussions during the workshop focused on the following: (1) premarket assessment, during which clinical trial data are used to assess benefit and risk; (2) communication of that information to prescribing physicians and their patients; (3) healthcare decisions made by prescribing physicians and their patients; and (4) the accumulation of benefit-risk information from postmarketing experience, which feeds back into the other phases. Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary explains in detail the discussions during this workshop.
Autor:
AA. VV.)
Características técnicas:
- Tamaño cerrado 152 x 229 mm
- 98 páginas interiores
- Tapa rústica
- Encuadernación lomo cuadrado
En Webook cuidamos el medio ambiente, imprimimos lo justo y este libro lo haremos especialmente para ti
Autores WeBook
María Beatriz Robles Bruzzone
Conoce a María Beatriz Robles Bruzzone, autora de Mi cadena de Milagros. Una historia real de fe, resiliencia y esperanza escrita desde Chile.
Club Andino escolar de Coyhaique
Daniel Wulf González, coyhaiquino de corazón, lleva el esquí en la sangre desde los 3 años. Conoce la historia del hombre detrás del libro que rescata la memoria del Club...
Paola Cofré Arancibia
Paola Cofré Arancibia es una Diseñadora de Ambientes y docente con más de 15 años de trayectoria, cuya carrera fusiona el diseño de alta gama con la comunicación emocional. Como...